[HTML][HTML] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

A Trifan, C Stanciu, I Girleanu, OC Stoica… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence

ML Maes, DR Fixen… - Therapeutic advances in …, 2017 - journals.sagepub.com
Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …

[HTML][HTML] Risk factors for Clostridium difficile infections–an overview of the evidence base and challenges in data synthesis

P Eze, E Balsells, MH Kyaw, H Nair - Journal of global health, 2017 - ncbi.nlm.nih.gov
Background Recognition of a broad spectrum of disease and development of Clostridium
difficile infection (CDI) and recurrent CDI (rCDI) in populations previously considered to be …

Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study

CF Tsai, MH Chen, YP Wang, CJ Chu, YH Huang… - Gastroenterology, 2017 - Elsevier
Background & Aims Hepatic encephalopathy (HE) is a serious complication of cirrhosis and
is associated with gut dysbiosis. Proton pump inhibitors (PPIs), frequently prescribed to …

Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease

E Ness-Jensen, J Lagergren - Best practice & research Clinical …, 2017 - Elsevier
Gastro-oesophageal reflux disease (GORD) develops when reflux of gastric content causes
troublesome symptoms or complications. The main symptoms are heartburn and acid …

Long‐term use of proton pump inhibitors and prevalence of disease‐and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study

SM Wallerstedt, J Fastbom, J Linke… - … and drug safety, 2017 - Wiley Online Library
Purpose To analyse the prevalence of long‐term use of proton pump inhibitors (PPI) with
respect to underlying diseases and drugs, and to find predictors for such treatment when an …

[HTML][HTML] Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis …

M Azab, L Doo, DH Doo, Y Elmofti, M Ahmed… - Gut and liver, 2017 - ncbi.nlm.nih.gov
Methods A systematic search of PubMed, MEDLINE/Ovid, Cumulative Index to Nursing and
Allied Health Literature (CINAHL), Web of Science, and Google Scholar through August 19 …

[HTML][HTML] Acid-suppressive therapy and risk of infections: pros and cons

L Fisher, A Fisher - Clinical drug investigation, 2017 - Springer
This narrative review summarises the benefits, risks and appropriate use of acid-
suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …

Association between proton pump inhibitors and microscopic colitis: implications for practice and future research

EH Law, M Badowski, YT Hung… - Annals of …, 2017 - journals.sagepub.com
Objective: Microscopic colitis (MC) is a chronic inflammatory disease of the colon that is
characterized by chronic, watery, nonbloody diarrhea. Concern regarding a potential …

Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic …

Y Dai, Y Zhang, D Li, J Ye, W Chen… - … and Alternative Medicine, 2017 - Wiley Online Library
Modified Banxia Xiexin decoction (MBXD) is a classical Chinese herbal formula in treating
gastroesophageal reflux disease (GERD) for long time, but the efficacy of it is still …